# Brexogen

**Canonical:** https://apis.io/providers/brexogen/  
**Website:** http://brexogen.com  
**APIs profiled:** 0

Brexogen is a biotechnology company focused on developing exosome‑based therapeutics for dermatological and autoimmune conditions. Founded in 2020, the firm combines advanced RNA‑delivery platforms with proprietary pipelines to create next‑generation treatments. Brexogen’s public website provides detailed information on its pipeline, research collaborations, leadership team, and investor relations, indicating an active presence in the biotech sector.

## Kin Score — 3.3 / 100 (minimal)

Scored 2026-10-04 under rubric 0.23.0.

| Facet | Score |
|---|---|
| Discoverability | 44.6 |
| Contract Quality | 0.0 |
| Contract Governance | 0.0 |
| Operational Transparency | 0.0 |
| Developer Ergonomics | 0.0 |
| Access Clarity | 0.0 |

Regulatory layer — **Health**: 4.7 (matched via tags).

## Agent readiness — 0.0 (human-only)

| Dimension | Value |
|---|---|
| Spec Presence | no |
| Agentic Access | no |
| Reversibility Documented | no |
| MCP Server | no |
| Auth Clarity | no |
| Idempotency | no |
| Error Semantics | no |
| OpenAPI Examples | no |
| Rate Limit Signal | no |
| Event Surface Described | no |
| Agent Skills | no |
| Well Known Catalog | no |
| Consent Identity | no |
| Agent Card | no |
| Dry Run Mode | no |
| Delegated Identity | no |
| Protected Resource Metadata | no |
| Dynamic Client Registration | no |
| Agentic Commerce | no |

## Security (1)

- **Brexogen Domain Security** — no transport/DNS hardening detected

## Tags

Company, Biotechnology, Therapeutics, Exosomes, Healthcare

---

Profiled by [API Evangelist](https://apievangelist.com) and published on [APIs.io](https://apis.io/providers/brexogen/). Scores are computed from the provider's own public artifacts under a published rubric.